Join our mailing list
Get exclusive deals and learn about new products!
Reliable shipping
Flexible returns
This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.
Published by: Springer
Publication Date: 2016-06-06
Format: Hardcover
ISBN-13: 9783319339115
DOI: 10.1007/978-3-319-33913-9
Dimensions: 235cm x155cm
Pages: 498